These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30836916)
1. Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents. Kalani K; Chaturvedi V; Trivedi P; Tondon S; Srivastava SK Curr Top Med Chem; 2019; 19(8):594-599. PubMed ID: 30836916 [TBL] [Abstract][Full Text] [Related]
2. In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents. Kalani K; Alam S; Chaturvedi V; Singh S; Khan F; Srivastava SK Curr Top Med Chem; 2019; 19(8):633-644. PubMed ID: 30834834 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of dihydroartemisinin-fluoroquinolone conjugates as a novel type of potential antitubercular agents. Zhou FW; Lei HS; Fan L; Jiang L; Liu J; Peng XM; Xu XR; Chen L; Zhou CH; Zou YY; Liu CP; He ZQ; Yang DC Bioorg Med Chem Lett; 2014 Apr; 24(8):1912-7. PubMed ID: 24684842 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents. Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis. Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification. Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540 [TBL] [Abstract][Full Text] [Related]
7. Anti-tubercular agents from Glycyrrhiza glabra. Kalani K; Chaturvedi V; Alam S; Khan F; Srivastava SK Curr Top Med Chem; 2015; 15(11):1043-9. PubMed ID: 25786503 [TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis. Hussain A; Rather MA; Bhat ZS; Majeed A; Maqbool M; Shah AM; Aga MA; Shah A; Mushtaq S; Sangwan PL; Hassan QP; Ahmad Z Int J Antimicrob Agents; 2019 Jan; 53(1):49-53. PubMed ID: 30267759 [TBL] [Abstract][Full Text] [Related]
9. Isoniazid derivatives and their anti-tubercular activity. Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives. Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related]
12. Discovery of anti-microbial and anti-tubercular molecules from Fusarium solani: an endophyte of Glycyrrhiza glabra. Shah A; Rather MA; Hassan QP; Aga MA; Mushtaq S; Shah AM; Hussain A; Baba SA; Ahmad Z J Appl Microbiol; 2017 May; 122(5):1168-1176. PubMed ID: 28150900 [TBL] [Abstract][Full Text] [Related]
13. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis. De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles. Cordeiro R; Kachroo M Bioorg Med Chem Lett; 2020 Dec; 30(24):127655. PubMed ID: 33130292 [TBL] [Abstract][Full Text] [Related]
15. 3-benzylidene-4-chromanones: a novel cluster of anti-tubercular agents. Das U; Lorand T; Dimmock SG; Perjesi P; Dimmock JR J Enzyme Inhib Med Chem; 2015 Apr; 30(2):259-63. PubMed ID: 24939095 [TBL] [Abstract][Full Text] [Related]
16. Recent advances of imidazole-containing derivatives as anti-tubercular agents. Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148 [TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone derivatives and their anti-tubercular activities. Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980 [TBL] [Abstract][Full Text] [Related]
18. Recent developments of coumarin-containing derivatives and their anti-tubercular activity. Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250 [TBL] [Abstract][Full Text] [Related]
19. Anti-Mycobacterial Peroxides: A New Class of Agents for Development Against Tuberculosis. van der Westhuyzen CW; Haynes RK; Panayides JL; Wiid I; Parkinson CJ Med Chem; 2020; 16(3):392-402. PubMed ID: 31208310 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains. da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]